FdaApplication
NDA 022083
Identifiers
- fda_app_no: NDA022083
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | NDA |
| approval_date | 2007-07-06 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXELON | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL |
| EXELON | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL |
| EXELON | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL |
3 products